Neuropathic pain: targeting the melatonin MT<sub>2</sub> receptor
Neuropathic pain affects a large proportion of the population and reduces a person’s ability to perform optimally. In South Africa, there are a host of factors that hinder the correct diagnosis and treatment of neuropathic pain. Patients suffering from neuropathic pain are treated suboptimally with...
Enregistré dans:
| Auteurs principaux: | N. Smith, H. Ismail, N. Schellack |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
AOSIS
2016
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/050c4c36cf34433d875f8f064600d765 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Ocular Neuropathic Pain: An Overview Focusing on Ocular Surface Pains
par: Ebrahimiadib N, et autres
Publié: (2020) -
Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists
par: Coluzzi F, et autres
Publié: (2020) -
Intrathecal interleukin-1β decreases sigma-1 receptor expression in spinal astrocytes in a murine model of neuropathic pain
par: Sheu-Ran Choi, et autres
Publié: (2021) -
Exercise for Neuropathic Pain: A Systematic Review and Expert Consensus
par: Yong-Hui Zhang, et autres
Publié: (2021) -
The Validity and Reliability of a New Modified Persian Version of DN4 to Discriminate Non-neuropathic from Neuropathic
par: Seyed Pezhman Madani, et autres
Publié: (2021)